Friday, July 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “bendamustine” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 15
Total indexed 20,548
Sponsors 1,771

Quick answer

Showing 15 pipeline programs matching "bendamustine" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

15 results for “bendamustine” Back to intelligence hub

Search results

  1. Bendamustine

    Hoffmann-La Roche

    Chronic Lymphocytic Leukemia

    phase 3 small molecule completed

    1 trial
  2. Bendamustine HCl

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma

    phase 3 small molecule completed

    1 trial
  3. Bendamustine hydrochloride

    Teva Pharma GmbH

    Non-Hodgkin Lymphoma

    phase 3 small molecule completed

    1 trial
  4. bendamustine

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma

    phase 3 small molecule completed

    2 trials
  5. Bendamustine

    Adaptive Biotechnologies Corp

    Lymphoma

    phase 2 small molecule active

    1 trial
  6. Bendamustine

    Teva Pharma GmbH

    Mantle Cell Lymphoma

    phase 2 small molecule completed

    1 trial
  7. Bendamustine

    Teva Pharma GmbH

    Leukemia

    phase 2 small molecule completed

    1 trial
  8. Bendamustine hydrochloride

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma (NHL)

    phase 2 small molecule completed

    1 trial
  9. IIT2025111

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Waldenström Macroglobulinemia (WM)

    phase 2 small molecule active

    1 trial
  10. TRU-016 and bendamustine

    Aptevo Therapeutics

    Chronic Lymphocytic Leukemia (CLL)

    phase 2 small molecule completed

    1 trial
  11. bendamustine

    Teva Pharma GmbH

    Hodgkin Lymphoma

    phase 2 small molecule active

    2 trials
  12. bendamustine

    Teva Pharma GmbH

    Multiple Myeloma

    phase 2 small molecule completed

    1 trial
  13. bendamustine and rituximab

    Teva Pharma GmbH

    Non-Hodgkin's Lymphoma

    phase 2 small molecule completed

    1 trial
  14. bendamustine

    Teva Pharma GmbH

    Malignancy

    phase 1 small molecule completed

    1 trial
  15. FL-ZBG-01

    The First People's Hospital of Lianyungang

    Follicular Lymphoma

    small molecule active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.